{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2025\/code-json\/54.1-3434.1.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2025\/code-text\/54.1-3434.1.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2025\/code-xml\/54.1-3434.1.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2025\/code-html\/54.1-3434.1.html"}],"law_id":77369,"edition_id":1,"section_id":77369,"structure_id":15723,"section_number":"54.1-3434.1","catch_line":"Nonresident pharmacies to register with Board","history":"1990, c. 270; 1994, c. 300; 2000, c. 882; 2005, cc. 115, 637, 678; 2006, c. 397; 2008, cc. 79, 618; 2011, c. 124; 2013, cc. 412, 544, 765; 2016, c. 221.","full_text":"A\n\nAny pharmacy located outside the Commonwealth that ships, mails, or delivers, in any manner, Schedule II through VI drugs or devices pursuant to a prescription into the Commonwealth shall be considered a nonresident pharmacy, shall be registered with the Board, shall designate a pharmacist in charge who is licensed as a pharmacist in Virginia and is responsible for the pharmacy&#8217;s compliance with this chapter, and shall disclose to the Board all of the following:1\n\nThe location, names, and titles of all principal corporate officers and the name and Virginia license number of the designated pharmacist in charge, if applicable. A report containing this information shall be made on an annual basis and within 30 days after any change of office, corporate officer, or pharmacist in charge.2\n\nThat it maintains, at all times, a current unrestricted license, permit, certificate, or registration to conduct the pharmacy in compliance with the laws of the jurisdiction, within the United States or within another jurisdiction that may lawfully deliver prescription drugs directly or indirectly to consumers within the United States, in which it is a resident. The pharmacy shall also certify that it complies with all lawful directions and requests for information from the regulatory or licensing agency of the jurisdiction in which it is licensed as well as with all requests for information made by the Board pursuant to this section.3\n\nAs a prerequisite to registering or renewing a registration with the Board, the nonresident pharmacy shall submit a copy of a current inspection report resulting from an inspection conducted by the regulatory or licensing agency of the jurisdiction in which it is located that indicates compliance with the requirements of this chapter, including compliance with USP-NF standards for pharmacies performing sterile and non-sterile compounding. The inspection report shall be deemed current for the purpose of this subdivision if the inspection was conducted (i) no more than six months prior to the date of submission of an application for registration with the Board or (ii) no more than two years prior to the date of submission of an application for renewal of a registration with the Board. However, if the nonresident pharmacy has not been inspected by the regulatory or licensing agency of the jurisdiction in which it is licensed within the required period, the Board may accept an inspection report or other documentation from another entity that is satisfactory to the Board or the Board may cause an inspection to be conducted by its duly authorized agent and may charge an inspection fee in an amount sufficient to cover the costs of the inspection.4\n\nFor a nonresident pharmacy that dispenses more than 50 percent of its total prescription volume pursuant to an original prescription order received as a result of solicitation on the Internet, including the solicitation by electronic mail, that it is credentialed and has been inspected and that it has received certification from the National Association of Boards of Pharmacy that it is a Verified Internet Pharmacy Practice Site, or has received certification from a substantially similar program approved by the Board. The Board may, in its discretion, waive the requirements of this subdivision for a nonresident pharmacy that only does business within the Commonwealth in limited transactions.5\n\nThat it maintains its records of prescription drugs or dangerous drugs or devices dispensed to patients in the Commonwealth so that the records are readily retrievable from the records of other drugs dispensed and provides a copy or report of such dispensing records to the Board, its authorized agents, or any agent designated by the Superintendent of the Department of State Police upon request within seven days of receipt of a request.6\n\nThat its pharmacists do not knowingly fill or dispense a prescription for a patient in Virginia in violation of &#xA7; 54.1-3303 and that it has informed its pharmacists that a pharmacist who dispenses a prescription that he knows or should have known was not written pursuant to a bona fide practitioner-patient relationship is guilty of unlawful distribution of a controlled substance in violation of &#xA7; 18.2-248.7\n\nThat it maintains a continuous quality improvement program as required of resident pharmacies, pursuant to &#xA7; 54.1-3434.03.\n\t\t\t\tThe requirement that a nonresident pharmacy have a Virginia licensed pharmacist in charge shall not apply to a registered nonresident pharmacy that provides services as a pharmacy benefits administrator.B\n\nAny pharmacy subject to this section shall, during its regular hours of operation, but not less than six days per week, and for a minimum of 40 hours per week, provide a toll-free telephone service to facilitate communication between patients in the Commonwealth and a pharmacist at the pharmacy who has access to the patient&#8217;s records. This toll-free number shall be disclosed on a label affixed to each container of drugs dispensed to patients in the Commonwealth.C\n\nPharmacies subject to this section shall comply with the reporting requirements of the Prescription Monitoring Program as set forth in &#xA7; 54.1-2521.D\n\nThe registration fee shall be the fee specified for pharmacies within Virginia.E\n\nA nonresident pharmacy shall only deliver controlled substances that are dispensed pursuant to a prescription, directly to the consumer or his designated agent, or directly to a pharmacy located in Virginia pursuant to regulations of the Board.F\n\nPharmacies subject to this section shall comply with the requirements set forth in &#xA7; 54.1-3408.04 relating to dispensing of an interchangeable biosimilar in the place of a prescribed biological product.G\n\nEvery nonresident pharmacy shall comply with federal requirements for an electronic, interoperable system to identify, trace, and verify prescription drugs as they are distributed.","order_by":null,"text":{"0":{"id":277514,"text":"Any pharmacy located outside the Commonwealth that ships, mails, or delivers, in any manner, Schedule II through VI drugs or devices pursuant to a prescription into the Commonwealth shall be considered a nonresident pharmacy, shall be registered with the Board, shall designate a pharmacist in charge who is licensed as a pharmacist in Virginia and is responsible for the pharmacy&#8217;s compliance with this chapter, and shall disclose to the Board all of the following:","type":"section","prefixes":["A"],"prefix":"A","entire_prefix":"A","prefix_anchor":"A","level":1,"next_prefix":"A1"},"1":{"id":277515,"text":"The location, names, and titles of all principal corporate officers and the name and Virginia license number of the designated pharmacist in charge, if applicable. A report containing this information shall be made on an annual basis and within 30 days after any change of office, corporate officer, or pharmacist in charge.","type":"section","prefixes":["A","1"],"prefix":"1","entire_prefix":"A1","prefix_anchor":"A1","level":2,"prior_prefix":"A","next_prefix":"A2"},"2":{"id":277516,"text":"That it maintains, at all times, a current unrestricted license, permit, certificate, or registration to conduct the pharmacy in compliance with the laws of the jurisdiction, within the United States or within another jurisdiction that may lawfully deliver prescription drugs directly or indirectly to consumers within the United States, in which it is a resident. The pharmacy shall also certify that it complies with all lawful directions and requests for information from the regulatory or licensing agency of the jurisdiction in which it is licensed as well as with all requests for information made by the Board pursuant to this section.","type":"section","prefixes":["A","2"],"prefix":"2","entire_prefix":"A2","prefix_anchor":"A2","level":2,"prior_prefix":"A1","next_prefix":"A3"},"3":{"id":277517,"text":"As a prerequisite to registering or renewing a registration with the Board, the nonresident pharmacy shall submit a copy of a current inspection report resulting from an inspection conducted by the regulatory or licensing agency of the jurisdiction in which it is located that indicates compliance with the requirements of this chapter, including compliance with USP-NF standards for pharmacies performing sterile and non-sterile compounding. The inspection report shall be deemed current for the purpose of this subdivision if the inspection was conducted (i) no more than six months prior to the date of submission of an application for registration with the Board or (ii) no more than two years prior to the date of submission of an application for renewal of a registration with the Board. However, if the nonresident pharmacy has not been inspected by the regulatory or licensing agency of the jurisdiction in which it is licensed within the required period, the Board may accept an inspection report or other documentation from another entity that is satisfactory to the Board or the Board may cause an inspection to be conducted by its duly authorized agent and may charge an inspection fee in an amount sufficient to cover the costs of the inspection.","type":"section","prefixes":["A","3"],"prefix":"3","entire_prefix":"A3","prefix_anchor":"A3","level":2,"prior_prefix":"A2","next_prefix":"A4"},"4":{"id":277518,"text":"For a nonresident pharmacy that dispenses more than 50 percent of its total prescription volume pursuant to an original prescription order received as a result of solicitation on the Internet, including the solicitation by electronic mail, that it is credentialed and has been inspected and that it has received certification from the National Association of Boards of Pharmacy that it is a Verified Internet Pharmacy Practice Site, or has received certification from a substantially similar program approved by the Board. The Board may, in its discretion, waive the requirements of this subdivision for a nonresident pharmacy that only does business within the Commonwealth in limited transactions.","type":"section","prefixes":["A","4"],"prefix":"4","entire_prefix":"A4","prefix_anchor":"A4","level":2,"prior_prefix":"A3","next_prefix":"A5"},"5":{"id":277519,"text":"That it maintains its records of prescription drugs or dangerous drugs or devices dispensed to patients in the Commonwealth so that the records are readily retrievable from the records of other drugs dispensed and provides a copy or report of such dispensing records to the Board, its authorized agents, or any agent designated by the Superintendent of the Department of State Police upon request within seven days of receipt of a request.","type":"section","prefixes":["A","5"],"prefix":"5","entire_prefix":"A5","prefix_anchor":"A5","level":2,"prior_prefix":"A4","next_prefix":"A6"},"6":{"id":277520,"text":"That its pharmacists do not knowingly fill or dispense a prescription for a patient in Virginia in violation of &#xA7; 54.1-3303 and that it has informed its pharmacists that a pharmacist who dispenses a prescription that he knows or should have known was not written pursuant to a bona fide practitioner-patient relationship is guilty of unlawful distribution of a controlled substance in violation of &#xA7; 18.2-248.","type":"section","prefixes":["A","6"],"prefix":"6","entire_prefix":"A6","prefix_anchor":"A6","level":2,"prior_prefix":"A5","next_prefix":"A7"},"7":{"id":277521,"text":"That it maintains a continuous quality improvement program as required of resident pharmacies, pursuant to &#xA7; 54.1-3434.03.\n\t\t\t\tThe requirement that a nonresident pharmacy have a Virginia licensed pharmacist in charge shall not apply to a registered nonresident pharmacy that provides services as a pharmacy benefits administrator.","type":"section","prefixes":["A","7"],"prefix":"7","entire_prefix":"A7","prefix_anchor":"A7","level":2,"prior_prefix":"A6","next_prefix":"B"},"8":{"id":277522,"text":"Any pharmacy subject to this section shall, during its regular hours of operation, but not less than six days per week, and for a minimum of 40 hours per week, provide a toll-free telephone service to facilitate communication between patients in the Commonwealth and a pharmacist at the pharmacy who has access to the patient&#8217;s records. This toll-free number shall be disclosed on a label affixed to each container of drugs dispensed to patients in the Commonwealth.","type":"section","prefixes":["B"],"prefix":"B","entire_prefix":"B","prefix_anchor":"B","level":1,"prior_prefix":"A7","next_prefix":"C"},"9":{"id":277523,"text":"Pharmacies subject to this section shall comply with the reporting requirements of the Prescription Monitoring Program as set forth in &#xA7; 54.1-2521.","type":"section","prefixes":["C"],"prefix":"C","entire_prefix":"C","prefix_anchor":"C","level":1,"prior_prefix":"B","next_prefix":"D"},"10":{"id":277524,"text":"The registration fee shall be the fee specified for pharmacies within Virginia.","type":"section","prefixes":["D"],"prefix":"D","entire_prefix":"D","prefix_anchor":"D","level":1,"prior_prefix":"C","next_prefix":"E"},"11":{"id":277525,"text":"A nonresident pharmacy shall only deliver controlled substances that are dispensed pursuant to a prescription, directly to the consumer or his designated agent, or directly to a pharmacy located in Virginia pursuant to regulations of the Board.","type":"section","prefixes":["E"],"prefix":"E","entire_prefix":"E","prefix_anchor":"E","level":1,"prior_prefix":"D","next_prefix":"F"},"12":{"id":277526,"text":"Pharmacies subject to this section shall comply with the requirements set forth in &#xA7; 54.1-3408.04 relating to dispensing of an interchangeable biosimilar in the place of a prescribed biological product.","type":"section","prefixes":["F"],"prefix":"F","entire_prefix":"F","prefix_anchor":"F","level":1,"prior_prefix":"E","next_prefix":"G"},"13":{"id":277527,"text":"Every nonresident pharmacy shall comply with federal requirements for an electronic, interoperable system to identify, trace, and verify prescription drugs as they are distributed.","type":"section","prefixes":["G"],"prefix":"G","entire_prefix":"G","prefix_anchor":"G","level":1,"prior_prefix":"F"}},"ancestry":[{"id":15723,"edition_id":1,"name":"Registration of Nonresident Pharmacies","identifier":"2.1","label":"article","depth":4,"order_by":1,"parent_id":13240,"metadata":{},"date_created":"2026-06-26 03:58:22","date_modified":"2026-06-26 03:58:22","permalink":{"id":243473,"object_type":"structure","relational_id":15723,"identifier":"2.1","token":"54.1\/III\/34\/2.1","url":"\/54.1\/III\/34\/2.1\/","edition_id":1,"permalink":0,"preferred":1}},{"id":13240,"edition_id":1,"name":"Drug Control Act","identifier":"34","label":"chapter","depth":3,"order_by":1,"parent_id":12758,"metadata":{},"date_created":"2026-06-26 03:44:30","date_modified":"2026-06-26 03:44:30","permalink":{"id":243223,"object_type":"structure","relational_id":13240,"identifier":"34","token":"54.1\/III\/34","url":"\/54.1\/III\/34\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12758,"edition_id":1,"name":"Professions and Occupations Regulated by Boards Within the Department of Health Professions","identifier":"III","label":"subtitle","depth":2,"order_by":1,"parent_id":12754,"metadata":{},"date_created":"2026-06-26 03:43:51","date_modified":"2026-06-26 03:43:51","permalink":{"id":241105,"object_type":"structure","relational_id":12758,"identifier":"III","token":"54.1\/III","url":"\/54.1\/III\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12754,"edition_id":1,"name":"Professions and Occupations","identifier":"54.1","label":"title","depth":1,"order_by":1,"parent_id":null,"metadata":{},"date_created":"2026-06-26 03:43:51","date_modified":"2026-06-26 03:43:51","permalink":{"id":239313,"object_type":"structure","relational_id":12754,"identifier":"54.1","token":"54.1","url":"\/54.1\/","edition_id":1,"permalink":0,"preferred":1}}],"structure_contents":[{"id":77369,"structure_id":15723,"section_number":"54.1-3434.1","catch_line":"Nonresident pharmacies to register with Board","url":"\/54.1-3434.1\/","token":"54.1\/III\/34\/2.1\/54.1-3434.1","metadata":false},{"id":61468,"structure_id":15723,"section_number":"54.1-3434.2","catch_line":"Permit to be issued","url":"\/54.1-3434.2\/","token":"54.1\/III\/34\/2.1\/54.1-3434.2","metadata":false},{"id":87354,"structure_id":15723,"section_number":"54.1-3434.3","catch_line":"Denial, revocation, suspension of registration, summary proceedings","url":"\/54.1-3434.3\/","token":"54.1\/III\/34\/2.1\/54.1-3434.3","metadata":false},{"id":60281,"structure_id":15723,"section_number":"54.1-3434.4","catch_line":"Prohibited acts","url":"\/54.1-3434.4\/","token":"54.1\/III\/34\/2.1\/54.1-3434.4","metadata":false},{"id":85801,"structure_id":15723,"section_number":"54.1-3434.5","catch_line":"Nonresident outsourcing facilities to register with the Board","url":"\/54.1-3434.5\/","token":"54.1\/III\/34\/2.1\/54.1-3434.5","metadata":false}],"next_section":{"id":61468,"structure_id":15723,"section_number":"54.1-3434.2","catch_line":"Permit to be issued","url":"\/54.1-3434.2\/","token":"54.1\/III\/34\/2.1\/54.1-3434.2","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/54.1-3434.1\/","history_text":"<p>This law was first created in 1990. The record of its establishment is cataloged in chapter 270 of that year\u2019s edition of \u201cActs of Assembly,\u201d the annual state publication listing all changes made to the Code of Virginia in that year. Unfortunately, the 1990 \u201cActs\u201d aren\u2019t available online. It has been modified 8 times. Those modifications are cataloged by \u201cThe Acts of Assembly,\u201d a state publication, by year and chapter. Those modifications that can be read on the General Assembly\u2019s website will be linked accordingly. Those modifications are as follows: in 1994, chapter <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?941+ful+CHAP0300\">300<\/a>; in 2000, chapter <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?001+ful+CHAP0882\">882<\/a>; in 2005, chapters <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?051+ful+CHAP0115\">115<\/a>, <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?051+ful+CHAP0637\">637<\/a>, and <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?051+ful+CHAP0678\">678<\/a>; in 2006, chapter <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?061+ful+CHAP0397\">397<\/a>; in 2008, chapters <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?081+ful+CHAP0079\">79<\/a> and <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?081+ful+CHAP0618\">618<\/a>; in 2011, chapter <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?111+ful+CHAP0124\">124<\/a>; in 2013, chapters <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?131+ful+CHAP0412\">412<\/a>, <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?131+ful+CHAP0544\">544<\/a>, and <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?131+ful+CHAP0765\">765<\/a>; in 2016, chapter <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?161+ful+CHAP0221\">221<\/a>.<\/p>","references":[{"id":61468,"section_number":"54.1-3434.2","catch_line":"Permit to be issued","order_by":null,"url":"\/54.1-3434.2\/"},{"id":58671,"section_number":"54.1-3435.3:1","catch_line":"Registration of nonresident medical equipment suppliers; renewal; fee","order_by":null,"url":"\/54.1-3435.3_1\/"}],"refers_to":[{"id":85347,"section_number":"54.1-3303","catch_line":"Prescriptions to be issued and drugs to be dispensed for medical or therapeutic purposes only","order_by":null,"url":"\/54.1-3303\/"},{"id":61115,"section_number":"54.1-3408.04","catch_line":"Dispensing of interchangeable biosimilars permitted","order_by":null,"url":"\/54.1-3408.04\/"},{"id":65752,"section_number":"54.1-3434.03","catch_line":"Continuous quality improvement program","order_by":null,"url":"\/54.1-3434.03\/"}],"permalink":{"id":243475,"object_type":"law","relational_id":77369,"identifier":"54.1-3434.1","token":"54.1\/III\/34\/2.1\/54.1-3434.1","url":"\/54.1-3434.1\/","edition_id":1,"permalink":0,"preferred":1},"url":"\/54.1-3434.1\/","token":"54.1\/III\/34\/2.1\/54.1-3434.1","dublin_core":{"Title":"Nonresident pharmacies to register with Board","Type":"Text","Format":"text\/html","Identifier":"\u00a7 54.1-3434.1","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t<section id=\"A\"><p><span class=\"prefix-number\">A.<\/span> Any pharmacy located outside the Commonwealth that ships, mails, or <span class=\"dictionary\">delivers<\/span>, in any manner, Schedule II through VI <span class=\"dictionary\">drugs<\/span> or <span class=\"dictionary\">devices<\/span> pursuant to a <span class=\"dictionary\">prescription<\/span> into the Commonwealth shall be considered a nonresident pharmacy, shall be registered with the <span class=\"dictionary\">Board<\/span>, shall designate a pharmacist in charge who is licensed as a pharmacist in Virginia and is responsible for the pharmacy&#8217;s compliance with this chapter, and shall disclose to the <span class=\"dictionary\">Board<\/span> all of the following: <a id=\"paragraph-277514\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-3434.1\/#A\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"A1\" class=\"indent-1\"><p><span class=\"prefix-number\">1.<\/span> The location, names, and titles of all principal corporate officers and the name and Virginia license number of the designated pharmacist in charge, if applicable. A report containing this information shall be made on an annual basis and within 30 days after any change of office, corporate officer, or pharmacist in charge. <a id=\"paragraph-277515\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-3434.1\/#A1\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"A2\" class=\"indent-1\"><p><span class=\"prefix-number\">2.<\/span> That it maintains, at all times, a current unrestricted license, permit, certificate, or registration to conduct the pharmacy in compliance with the <span class=\"dictionary\">laws<\/span> of the <span class=\"dictionary\">jurisdiction<\/span>, within the United States or within another <span class=\"dictionary\">jurisdiction<\/span> that may lawfully <span class=\"dictionary\">deliver<\/span> <span class=\"dictionary\">prescription drugs<\/span> directly or indirectly to consumers within the United States, in which it is a resident. The pharmacy shall also certify that it complies with all lawful directions and requests for information from the regulatory or licensing agency of the <span class=\"dictionary\">jurisdiction<\/span> in which it is licensed as well as with all requests for information made by the <span class=\"dictionary\">Board<\/span> pursuant to this section. <a id=\"paragraph-277516\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-3434.1\/#A2\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"A3\" class=\"indent-1\"><p><span class=\"prefix-number\">3.<\/span> As a prerequisite to registering or renewing a registration with the <span class=\"dictionary\">Board<\/span>, the nonresident pharmacy shall submit a copy of a current inspection report resulting from an inspection conducted by the regulatory or licensing agency of the <span class=\"dictionary\">jurisdiction<\/span> in which it is located that indicates compliance with the requirements of this chapter, including compliance with <span class=\"dictionary\">USP-NF<\/span> standards for pharmacies performing sterile and non-sterile <span class=\"dictionary\">compounding<\/span>. The inspection report shall be deemed current for the purpose of this subdivision if the inspection was conducted (i) no more than six months prior to the date of submission of an application for registration with the <span class=\"dictionary\">Board<\/span> or (ii) no more than two years prior to the date of submission of an application for renewal of a registration with the <span class=\"dictionary\">Board<\/span>. However, if the nonresident pharmacy has not been inspected by the regulatory or licensing agency of the <span class=\"dictionary\">jurisdiction<\/span> in which it is licensed within the required period, the <span class=\"dictionary\">Board<\/span> may accept an inspection report or other documentation from another entity that is satisfactory to the <span class=\"dictionary\">Board<\/span> or the <span class=\"dictionary\">Board<\/span> may cause an inspection to be conducted by its duly authorized <span class=\"dictionary\">agent<\/span> and may charge an inspection fee in an amount sufficient to cover the costs of the inspection. <a id=\"paragraph-277517\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-3434.1\/#A3\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"A4\" class=\"indent-1\"><p><span class=\"prefix-number\">4.<\/span> For a nonresident pharmacy that <span class=\"dictionary\">dispenses<\/span> more than 50 percent of its total prescription volume pursuant to an original prescription <span class=\"dictionary\">order<\/span> received as a result of solicitation on the Internet, including the solicitation by electronic mail, that it is credentialed and has been inspected and that it has received certification from the National Association of <span class=\"dictionary\">Boards<\/span> of Pharmacy that it is a Verified Internet Pharmacy Practice Site, or has received certification from a substantially similar program approved by the <span class=\"dictionary\">Board<\/span>. The <span class=\"dictionary\">Board<\/span> may, in its discretion, <span class=\"dictionary\">waive<\/span> the requirements of this subdivision for a nonresident pharmacy that only does business within the Commonwealth in limited transactions. <a id=\"paragraph-277518\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-3434.1\/#A4\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"A5\" class=\"indent-1\"><p><span class=\"prefix-number\">5.<\/span> That it maintains its records of <span class=\"dictionary\">prescription drugs<\/span> or dangerous drugs or <span class=\"dictionary\">devices<\/span> dispensed to patients in the Commonwealth so that the records are readily retrievable from the records of other drugs dispensed and provides a copy or report of such <span class=\"dictionary\">dispensing<\/span> records to the <span class=\"dictionary\">Board<\/span>, its authorized <span class=\"dictionary\">agents<\/span>, or any <span class=\"dictionary\">agent<\/span> designated by the Superintendent of the Department of State Police upon request within seven days of receipt of a request. <a id=\"paragraph-277519\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-3434.1\/#A5\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"A6\" class=\"indent-1\"><p><span class=\"prefix-number\">6.<\/span> That its pharmacists do not knowingly fill or <span class=\"dictionary\">dispense<\/span> a prescription for a patient in Virginia in violation of &#xA7; <a class=\"law\" title=\"Prescriptions to be issued and drugs to be dispensed for medical or therapeutic purposes only\" href=\"\/54.1-3303\/\">54.1-3303<\/a> and that it has informed its pharmacists that a pharmacist who <span class=\"dictionary\">dispenses<\/span> a prescription that he knows or should have known was not written pursuant to a bona fide <span class=\"dictionary\">practitioner<\/span>-patient relationship is guilty of unlawful distribution of a <span class=\"dictionary\">controlled substance<\/span> in violation of &#xA7; <a class=\"law\" title=\"Manufacturing, selling, giving, distributing, or possessing with intent to manufacture, sell, give, or distribute a controlled substance or an imitation controlled substance prohibited; penalties\" href=\"\/18.2-248\/\">18.2-248<\/a>. <a id=\"paragraph-277520\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-3434.1\/#A6\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"A7\" class=\"indent-1\"><p><span class=\"prefix-number\">7.<\/span> That it maintains a continuous quality improvement program as required of resident pharmacies, pursuant to &#xA7; <a class=\"law\" title=\"Continuous quality improvement program\" href=\"\/54.1-3434.03\/\">54.1-3434.03<\/a>.\n\t\t\t\tThe requirement that a nonresident pharmacy have a Virginia licensed pharmacist in charge shall not apply to a registered nonresident pharmacy that provides services as a pharmacy benefits administrator. <a id=\"paragraph-277521\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-3434.1\/#A7\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"B\"><p><span class=\"prefix-number\">B.<\/span> Any pharmacy subject to this section shall, during its regular hours of operation, but not less than six days per week, and for a minimum of 40 hours per week, provide a toll-free telephone service to facilitate communication between patients in the Commonwealth and a pharmacist at the pharmacy who has access to the patient&#8217;s records. This toll-free number shall be disclosed on a <span class=\"dictionary\">label<\/span> affixed to each container of drugs dispensed to patients in the Commonwealth. <a id=\"paragraph-277522\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-3434.1\/#B\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"C\"><p><span class=\"prefix-number\">C.<\/span> Pharmacies subject to this section shall comply with the reporting requirements of the Prescription Monitoring Program as set forth in &#xA7; <a class=\"law\" title=\"(Effective July 1, 2026) Reporting requirements\" href=\"\/54.1-2521\/\">54.1-2521<\/a>. <a id=\"paragraph-277523\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-3434.1\/#C\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"D\"><p><span class=\"prefix-number\">D.<\/span> The registration fee shall be the fee specified for pharmacies within Virginia. <a id=\"paragraph-277524\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-3434.1\/#D\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"E\"><p><span class=\"prefix-number\">E.<\/span> A nonresident pharmacy shall only <span class=\"dictionary\">deliver<\/span> <span class=\"dictionary\">controlled substances<\/span> that are dispensed pursuant to a prescription, directly to the consumer or his designated <span class=\"dictionary\">agent<\/span>, or directly to a pharmacy located in Virginia pursuant to regulations of the <span class=\"dictionary\">Board<\/span>. <a id=\"paragraph-277525\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-3434.1\/#E\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"F\"><p><span class=\"prefix-number\">F.<\/span> Pharmacies subject to this section shall comply with the requirements set forth in &#xA7; <a class=\"law\" title=\"Dispensing of interchangeable biosimilars permitted\" href=\"\/54.1-3408.04\/\">54.1-3408.04<\/a> relating to <span class=\"dictionary\">dispensing<\/span> of an <span class=\"dictionary\">interchangeable<\/span> <span class=\"dictionary\">biosimilar<\/span> in the place of a prescribed <span class=\"dictionary\">biological product<\/span>. <a id=\"paragraph-277526\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-3434.1\/#F\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"G\"><p><span class=\"prefix-number\">G.<\/span> Every nonresident pharmacy shall comply with federal requirements for an electronic, interoperable system to identify, trace, and verify <span class=\"dictionary\">prescription drugs<\/span> as they are distributed. <a id=\"paragraph-277527\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-3434.1\/#G\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>","plain_text":"                                 CODE OF VIRGINIA\n\nNONRESIDENT PHARMACIES TO REGISTER WITH BOARD (\u00a7 54.1-3434.1)\n\nA. Any pharmacy located outside the Commonwealth that ships, mails, or delivers,\nin any manner, Schedule II through VI drugs or devices pursuant to a\nprescription into the Commonwealth shall be considered a nonresident pharmacy,\nshall be registered with the Board, shall designate a pharmacist in charge who\nis licensed as a pharmacist in Virginia and is responsible for the\npharmacy&#8217;s compliance with this chapter, and shall disclose to the Board\nall of the following:\n\n   1. The location, names, and titles of all principal corporate officers and the\n   name and Virginia license number of the designated pharmacist in charge, if\n   applicable. A report containing this information shall be made on an annual\n   basis and within 30 days after any change of office, corporate officer, or\n   pharmacist in charge.\n\n   2. That it maintains, at all times, a current unrestricted license, permit,\n   certificate, or registration to conduct the pharmacy in compliance with the\n   laws of the jurisdiction, within the United States or within another\n   jurisdiction that may lawfully deliver prescription drugs directly or\n   indirectly to consumers within the United States, in which it is a resident.\n   The pharmacy shall also certify that it complies with all lawful directions\n   and requests for information from the regulatory or licensing agency of the\n   jurisdiction in which it is licensed as well as with all requests for\n   information made by the Board pursuant to this section.\n\n   3. As a prerequisite to registering or renewing a registration with the Board,\n   the nonresident pharmacy shall submit a copy of a current inspection report\n   resulting from an inspection conducted by the regulatory or licensing agency\n   of the jurisdiction in which it is located that indicates compliance with the\n   requirements of this chapter, including compliance with USP-NF standards for\n   pharmacies performing sterile and non-sterile compounding. The inspection\n   report shall be deemed current for the purpose of this subdivision if the\n   inspection was conducted (i) no more than six months prior to the date of\n   submission of an application for registration with the Board or (ii) no more\n   than two years prior to the date of submission of an application for renewal\n   of a registration with the Board. However, if the nonresident pharmacy has not\n   been inspected by the regulatory or licensing agency of the jurisdiction in\n   which it is licensed within the required period, the Board may accept an\n   inspection report or other documentation from another entity that is\n   satisfactory to the Board or the Board may cause an inspection to be conducted\n   by its duly authorized agent and may charge an inspection fee in an amount\n   sufficient to cover the costs of the inspection.\n\n   4. For a nonresident pharmacy that dispenses more than 50 percent of its total\n   prescription volume pursuant to an original prescription order received as a\n   result of solicitation on the Internet, including the solicitation by\n   electronic mail, that it is credentialed and has been inspected and that it\n   has received certification from the National Association of Boards of Pharmacy\n   that it is a Verified Internet Pharmacy Practice Site, or has received\n   certification from a substantially similar program approved by the Board. The\n   Board may, in its discretion, waive the requirements of this subdivision for a\n   nonresident pharmacy that only does business within the Commonwealth in\n   limited transactions.\n\n   5. That it maintains its records of prescription drugs or dangerous drugs or\n   devices dispensed to patients in the Commonwealth so that the records are\n   readily retrievable from the records of other drugs dispensed and provides a\n   copy or report of such dispensing records to the Board, its authorized agents,\n   or any agent designated by the Superintendent of the Department of State\n   Police upon request within seven days of receipt of a request.\n\n   6. That its pharmacists do not knowingly fill or dispense a prescription for a\n   patient in Virginia in violation of &#xA7; 54.1-3303 and that it has informed\n   its pharmacists that a pharmacist who dispenses a prescription that he knows\n   or should have known was not written pursuant to a bona fide\n   practitioner-patient relationship is guilty of unlawful distribution of a\n   controlled substance in violation of &#xA7; 18.2-248.\n\n   7. That it maintains a continuous quality improvement program as required of\n   resident pharmacies, pursuant to &#xA7; 54.1-3434.03.\n   \t\t\t\tThe requirement that a nonresident pharmacy have a Virginia licensed\n   pharmacist in charge shall not apply to a registered nonresident pharmacy that\n   provides services as a pharmacy benefits administrator.\n\nB. Any pharmacy subject to this section shall, during its regular hours of\noperation, but not less than six days per week, and for a minimum of 40 hours\nper week, provide a toll-free telephone service to facilitate communication\nbetween patients in the Commonwealth and a pharmacist at the pharmacy who has\naccess to the patient&#8217;s records. This toll-free number shall be disclosed\non a label affixed to each container of drugs dispensed to patients in the\nCommonwealth.\n\nC. Pharmacies subject to this section shall comply with the reporting\nrequirements of the Prescription Monitoring Program as set forth in &#xA7;\n54.1-2521.\n\nD. The registration fee shall be the fee specified for pharmacies within\nVirginia.\n\nE. A nonresident pharmacy shall only deliver controlled substances that are\ndispensed pursuant to a prescription, directly to the consumer or his designated\nagent, or directly to a pharmacy located in Virginia pursuant to regulations of\nthe Board.\n\nF. Pharmacies subject to this section shall comply with the requirements set\nforth in &#xA7; 54.1-3408.04 relating to dispensing of an interchangeable\nbiosimilar in the place of a prescribed biological product.\n\nG. Every nonresident pharmacy shall comply with federal requirements for an\nelectronic, interoperable system to identify, trace, and verify prescription\ndrugs as they are distributed.\n\nHISTORY: 1990, c. 270; 1994, c. 300; 2000, c. 882; 2005, cc. 115, 637, 678;\n2006, c. 397; 2008, cc. 79, 618; 2011, c. 124; 2013, cc. 412, 544, 765; 2016, c.\n221.","edition":{"id":1,"name":"2025","slug":"2025","date_created":"2026-06-21 22:39:22","date_modified":"2026-06-21 22:39:22","current":1,"order_by":1,"last_import":null}}